Neurotrope and Mount Sinai collaborate to develop Bryostatin-1 for NPC disease

Neurotrope Bioscience has entered into a collaboration agreement with Icahn School of Medicine at Mount Sinai to develop Bryostatin-1 in the treatment of Niemann-Pick Type C (NPC) disease.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news